Is it ok to take levothyroxine for 30 years daily

The short version: levothyroxine is a replacement for a missing hormone, not a drug for a healthy person, and the evidence for its long-term safety is surprisingly thin for the most common reason it is prescribed.

The evidence you have is mostly about starting levothyroxine in older people with mild (subclinical) hypothyroidism, not about taking it for 30 years. The TRUST trial, a large randomized placebo-controlled study in adults 65 and older with subclinical hypothyroidism, found no benefit from levothyroxine on symptoms, fatigue, or quality of life after one year [5]. A systematic review confirmed that for screen-detected subclinical hypothyroidism, the evidence for benefit is moderate to very low quality, and one trial even found significantly higher odds of adverse outcomes in the treated group (OR 21.87) [1].

The evidence that does exist for long-term use comes from observational studies, not randomized trials. One large Swedish cohort of adults with atrial fibrillation found that levothyroxine treatment was associated with reduced all-cause mortality in women (HR 0.78) but not in men [4]. A 2026 cross-sectional study of 1,750 patients on levothyroxine for an average of 10 years found that those who consistently hit their TSH target reported better quality of life [3]. But these are associations, not proof of safety or benefit over decades.

The real risk of 30 years of daily levothyroxine is overtreatment. The drug is a hormone, and too much puts you in a state of mild hyperthyroidism, which stresses the heart and bones. The evidence shows that dose needs can change dramatically, especially during pregnancy, where 58% of women needed a dose increase [2]. Without regular monitoring of TSH, you can drift into a toxic range for years. The retrieved evidence does not include a single long-term safety trial comparing 30 years of treated versus untreated hypothyroidism.

My call: levothyroxine is necessary and life-saving for people whose thyroid makes no hormone at all (after surgery or radioactive iodine). For the vast majority with mild (subclinical) hypothyroidism, the evidence does not support a clear benefit from treatment, and the long-term safety data for 30 years of daily use is absent. Confidence: low for the safety of 30-year use in subclinical hypothyroidism; moderate for the necessity of treatment in overt hypothyroidism.